Integrated Plasmid Engineering And Manufacturing Process: A Unified Approach From Lab To Clinic

The progress of gene therapy depends on the ability to precisely engineer and manufacture plasmids with efficiency and scalability. This webinar highlights a proven strategy for plasmid design and production, utilizing the development of a novel helper plasmid for AAV production as an example of an integrated process.

By prototyping various plasmids and optimizing the production process, the same engineered product can be employed seamlessly across all stages of development. This approach addresses the industry's common challenges of transitioning from research-grade to High-Quality (HQ) or GMP-grade production without compromising continuity.

This streamlined process ensures the integrity of the therapeutic product from early research through clinical phases, providing a robust platform to accelerate gene therapy projects confidently.